-+ 0.00%
-+ 0.00%
-+ 0.00%

IPO News | Bepsyth (301080.SZ) submitted another listing to the Hong Kong Stock Exchange

Zhitongcaijing·10/02/2026 00:09:16
Listen to the news

The Zhitong Finance App learned that according to the Hong Kong Stock Exchange's disclosure on September 30, Beijing Baipsis Biotechnology Co., Ltd. (abbreviation: Bepsis, 301080.SZ) has once again submitted a listing application to the main board of the Hong Kong Stock Exchange, with China Merchants Securities International as its sole sponsor. According to the prospectus, the company is mainly engaged in R&D, production and sales of recombinant proteins, antibodies and analytical test kits. According to Frost & Sullivan, the company ranked first among all Chinese suppliers in the global recombinant protein market and third among all suppliers in terms of revenue in 2025, with a global market share of 2.7%, compared to the combined market share of 33.0% of the top two market participants.

image.png